![Mini Oral_01](/var/esmo/storage/images/media/esmo-daily-reporter/images/tat-2023/mini-oral_01/17337797-1-eng-GB/mini-oral_01_i770.jpg)
New tools and methods are discussed for optimising investigation of precision therapeutics
Results of extensive genomic profiling and a Time-to-Event Continual Reassessment Method show some promise in investigating new treatments and targets in early-phase trials, despite not being ready for routine research